Analysis
Three different startups repriced to a new valuation multiple within five to nine months of their prior mark this week, the latest sign that 2026's fastest-growing AI, defense-tech and security names are being re-rated on a timeline closer to quarters than years.
The pattern: three repricings in one stretch
Two startups just repriced within months of their last round:
- [Nominal](/pulse/nominal-triples-3b-valuation-240m-series-c-2026) -- tripled to $3 billion eight months after setting a $1 billion mark.
- [Onodrim Industries](/pulse/onodrim-industries-300m-series-a-1-3b-valuation-2026) -- went from a seed round to a $1.3 billion valuation nine months later.
A third, Cyera, is reportedly closing in on an $800 million round at close to a $20 billion valuation, up from the $12 billion mark it set in June, with Cyberstarts alone committing about $300 million.
“- Onodrim Industries -- went from a seed round to a $1.3 billion valuation nine months later.”
None of the three needed a down round or rescue financing to justify the new mark -- the opposite of 2022's repricing cycle, when markdowns moved valuations down, not up.
Why the timeline is compressing
Each case follows a similar arc: a company shows a step-change in revenue or contract wins, and existing or new investors move fast to avoid missing the next round at a materially higher price. Nominal's customer base grew from roughly 60 organizations to more than 80 in the months since its March raise, and it landed a $71.2 million U.S. Air Force award in October. Onodrim's jump came as European governments accelerated defense-industrial spending.
The broader funding backdrop
The compressed timeline isn't isolated to a handful of companies. US Series A funding reached about $42 billion through October 2026, up roughly 60% year over year, even as the number of companies raising rounds held roughly flat -- meaning the same pool of Series A companies is raising meaningfully larger checks.
Value Add VC's own database tracks $174.1 billion in disclosed venture capital across 223 deals with a median round size of $86 million, a figure skewed upward by exactly this kind of rapid-fire megaround.
The counterweight
However, a valuation markup within five to nine months is not the same as proven, durable revenue -- none of Nominal, Onodrim or Cyera has disclosed audited revenue figures alongside their new marks, only growth rates and contract wins reported by the companies themselves. Fast repricing also concentrates capital risk in a narrow set of categories rather than spreading it across the broader startup market, and a pullback in any one of those categories would leave later investors holding marks set during the fastest part of the cycle.
What to watch
Whether Nominal, Onodrim and Cyera disclose real revenue or ARR figures at their next rounds -- or whether the next markup for any of them comes slower, or not at all -- will show whether this pace of repricing reflects real growth or a crowded field of investors chasing the same few categories. The next data point worth tracking is whether Series B and Series C investors, not just seed and Series A backers, start demanding the same speed.
